REGISTER
China's First Gene-Edited Pig Kidney Transplant Recipient Survives Over 200 Days

As of September 23, China's first recipient of a gene-edited pig kidney has survived for more than 200 days post-surgery. This achievement sets a new record for the longest survival in Asia in the field of xenotransplantation and ranks as the second-longest survival globally. The current world record is held by American patient Tim Andrews, who has survived for eight months after receiving a gene-edited pig kidney transplant.

"This marks a significant milestone in xenotransplantation for both China and the United States, crossing a critical threshold. The first six months post-transplant pose the highest risks for organ recipients. Surviving this period means overcoming hyperacute and accelerated acute rejection," Dr. Dengke Pan, founder of Chengdu Zhongke Aoge Biotechnology and the supplier of the donor pig for the surgery, told MedJ.

Dr. Wayne Hawthorne, transplant surgeon at the University of Sydney and former president of the International Xenotransplantation Association, noted that reaching six months of survival is a remarkable feat, indicating very promising progress, while achieving 12 months would be another milestone—a "wonderful long-term outcome."

China's first gene-edited pig kidney transplant recipient and family members, photographed at the patient's home. / Image source: Xijing Hospital


The Most Critical Six Months After the Transplant

The groundbreaking gene-edited pig kidney transplantation was successfully performed on March 6 this year.

Under the guidance of Academician Dr. Kefeng Dou of the Chinese Academy of Sciences, a multidisciplinary team from over 20 departments at Xijing Hospital of the Air Force Medical University collaborated to transplant the pig kidney into a 69-year-old patient with end-stage renal disease. This marked Asia's first and the world's fifth xenotransplantation procedure of its kind.

According to Xijing Hospital, the patient currently maintains a daily urine output of approximately 2000 mL, with normal blood creatinine levels. Key indicators dependent on renal regulation—such as water-electrolyte balance, blood pressure, and parathyroid function—remain stable, demonstrating the robust functionality and viability of the transplanted pig kidney.

Dr. Weijun Qin, Director of the Urology Department, explained that the first six months post-transplant represent a high-risk period for complications such as rejection and infection. Given the patient's multiple pre-existing comorbidities, precise monitoring and dynamic adjustment were particularly critical compared to typical xenotransplant cases. Through multidisciplinary collaboration, the hospital developed a distinctive "Xijing Protocol," offering hope for addressing the severe shortage of donor organs.

"Surviving beyond 180 days is a significant and encouraging milestone in xenotransplantation," Dr. Dengke Pan told MedJ. "This achievement also greatly boosts confidence for the patient and their family! Everyone hopes for the longest possible survival after transplantation."

The 180-day mark holds critical importance as a key observational threshold.
In February of this year, the U.S. FDA approved the world's first clinical trial of gene-edited pig kidney transplantation under an Investigational New Drug (IND) pathway. This milestone signifies that xenotransplantation has progressed beyond compassionate use cases to formally enter the phase of registered clinical research. As of September, the number of related INDs in the U.S. has increased to two.

A researcher from Zhongke Aoge informed MedJ that, per FDA requirements, all trial participants must complete approximately six months of follow-up post-surgery. Subsequently, lifelong monitoring will continue to track survival, pig kidney function, and potential zoonotic infections.

"The first six months are typically the most critical period for patients." A recent article in Nature noted that survival beyond six months indicates the patient has overcome major challenges associated with pig kidney transplantation, including managing immune rejection, anemia, and fluid balance.

Nature also cited academic opinions suggesting that if Dr. Tim Andrews survives for one year post-transplant, it would represent another milestone—achieving "long-term surgical prognosis."

China's first gene-edited pig kidney transplant recipient at 200 days post-surgery. / Image source: Xijing Hospital


A Distinctly Chinese Approach to Xenotransplantation

Compared with efforts in Europe and the U.S., China has demonstrated unique characteristics in donor pig breeding and post-transplant anti-rejection strategies. The pig kidney used in the Xijing Hospital surgery was developed by Dr. Dengke Pan’s team using a six-gene edited pig. The edits involved knocking out three key antigens responsible for rejection and introducing three protective "shield" genes. In contrast, donor pigs used in U.S. procedures often undergo 10 to 11 gene edits.

"More gene edits are not necessarily better. Our results show that the six-gene edited pig can support long-term survival," Dr. Pan stated, noting that excessive editing could burden the donor pig. Importantly, the Chinese patient achieved long-term survival without using CD154 antibody—a regimen employed by the U.S. team—indicating the high quality of the donor pig.

Pig Kidney Transplants Could Become Widespread Within 5 Years

Xenotransplantation has now become a national priority in China. According to a special project guide issued by the National Health Commission, research on medical-grade donor pig breeding and clinical translation of xenotransplantation is classified as a "competing for excellence" initiative. Pan revealed, "We have successfully completed five pig-to-monkey kidney transplants, with two surviving over 180 days and the longest exceeding 320 days, continuously setting new records in Asia."

Dr. Pan is confident that gene-edited pig kidney transplantation will become a routine procedure within five years. Dr. Kefeng Dou emphasized that with over 100 million people in China affected by chronic kidney disease, xenotransplantation offers hope in addressing the worldwide shortage of donor organs.

0
0
Loading